Novel Vaccines for Animal Health

VEROVACCiNES is a German biopharmaceutical company. We discover and develop innovative vaccine solutions, to protect animals against infectious diseases. Key is a novel, broadly applicable, yeast-based technology to generate modern recombinant combination vaccines.

HOW DOES THE TECHNOLOGY WORK?

VEROVACCiNES novel vaccines are based on recombinant strains of the yeast Kluyveromyces lactis, which stably express one or more antigens. 

Team

The team of VEROVACCiNES GmbH is built around talented researchers skilled in virology, molecular biology, veterinary medicine and process engineering.

Funding & Partners